BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 12010364)

  • 1. Comparative evaluation of the prognostic value of MUC1, MUC2, sialyl-Lewis(a) and sialyl-Lewis(x) antigens in colorectal adenocarcinoma.
    Baldus SE; Mönig SP; Hanisch FG; Zirbes TK; Flucke U; Oelert S; Zilkens G; Madejczik B; Thiele J; Schneider PM; Hölscher AH; Dienes HP
    Histopathology; 2002 May; 40(5):440-9. PubMed ID: 12010364
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of MUC1, MUC2 and oligosaccharide epitopes in breast cancer: prognostic significance of a sialylated MUC1 epitope.
    Baldus SE; Wienand JR; Werner JP; Landsberg S; Drebber U; Hanisch FG; Dienes HP
    Int J Oncol; 2005 Nov; 27(5):1289-97. PubMed ID: 16211224
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunoreactivity of Lewis blood group and mucin peptide core antigens: correlations with grade of dysplasia and malignant transformation in the colorectal adenoma-carcinoma sequence.
    Baldus SE; Hanisch FG; Pütz C; Flucke U; Mönig SP; Schneider PM; Thiele J; Hölscher AH; Dienes HP
    Histol Histopathol; 2002 Jan; 17(1):191-8. PubMed ID: 11813869
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation of the immunohistochemical reactivity of mucin peptide cores MUC1 and MUC2 with the histopathological subtype and prognosis of gastric carcinomas.
    Baldus SE; Zirbes TK; Engel S; Hanisch FG; Mönig SP; Lorenzen J; Glossmann J; Fromm S; Thiele J; Pichlmaier H; Dienes HP
    Int J Cancer; 1998 Apr; 79(2):133-8. PubMed ID: 9583726
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Expression and clinical significance of Mucin and E-cadherin in colorectal tumors].
    Yu XW; Rong W; Xu FL; Xu GY; Sun YR; Feng MY
    Ai Zheng; 2007 Nov; 26(11):1204-10. PubMed ID: 17991319
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential expression of mucin 1 and mucin 2 in colorectal cancer.
    Kasprzak A; Siodła E; Andrzejewska M; Szmeja J; Seraszek-Jaros A; Cofta S; Szaflarski W
    World J Gastroenterol; 2018 Sep; 24(36):4164-4177. PubMed ID: 30271081
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Racial differences in the prognostic usefulness of MUC1 and MUC2 in colorectal adenocarcinomas.
    Manne U; Weiss HL; Grizzle WE
    Clin Cancer Res; 2000 Oct; 6(10):4017-25. PubMed ID: 11051251
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of MUC1 and MUC2 mucins in extrahepatic bile duct carcinomas: its relationship with tumor progression and prognosis.
    Tamada S; Goto M; Nomoto M; Nagata K; Shimizu T; Tanaka S; Sakoda K; Imai K; Yonezawa S
    Pathol Int; 2002 Nov; 52(11):713-23. PubMed ID: 12685548
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of MUC1 and MUC2 mucins in gastric carcinomas: their relationship with clinicopathologic parameters and prognosis.
    Akyürek N; Akyol G; Dursun A; Yamaç D; Günel N
    Pathol Res Pract; 2002; 198(10):665-74. PubMed ID: 12498221
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Significance of MUC1 and MUC2 mucin expression in colorectal cancer.
    Ajioka Y; Allison LJ; Jass JR
    J Clin Pathol; 1996 Jul; 49(7):560-4. PubMed ID: 8813954
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Expression of mucin MUC1 and MUC2 in colorectal carcinoma and their clinical significance].
    Huang WB; Shi LH; Zhu XQ; Xu GX; Qi Q
    Ai Zheng; 2002 Nov; 21(11):1231-4. PubMed ID: 12526222
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic significance of mucins in colorectal cancer with different DNA mismatch-repair status.
    Lugli A; Zlobec I; Baker K; Minoo P; Tornillo L; Terracciano L; Jass JR
    J Clin Pathol; 2007 May; 60(5):534-9. PubMed ID: 16816167
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of new cancer biomarkers based on aberrant mucin glycoforms by in situ proximity ligation.
    Pinto R; Carvalho AS; Conze T; Magalhães A; Picco G; Burchell JM; Taylor-Papadimitriou J; Reis CA; Almeida R; Mandel U; Clausen H; Söderberg O; David L
    J Cell Mol Med; 2012 Jul; 16(7):1474-84. PubMed ID: 21883895
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunohistochemical expression of mucin antigens in gallbladder adenocarcinoma: MUC1-positive and MUC2-negative expression Is associated with vessel invasion and shortened survival.
    Hiraki T; Yamada S; Higashi M; Hatanaka K; Yokoyama S; Kitazono I; Goto Y; Kirishima M; Batra SK; Yonezawa S; Tanimoto A
    Histol Histopathol; 2017 Jun; 32(6):585-596. PubMed ID: 27672051
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of MUC1 and MUC2 mucin gene products in Barrett's metaplasia, dysplasia and adenocarcinoma: an immunopathological study with clinical correlation.
    Chinyama CN; Marshall RE; Owen WJ; Mason RC; Kothari D; Wilkinson ML; Sanderson JD
    Histopathology; 1999 Dec; 35(6):517-24. PubMed ID: 10583575
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of sialyl-Lewis x on MUC5AC and MUC1 mucins in pancreatic cancer tissues.
    Balmaña M; Duran A; Gomes C; Llop E; López-Martos R; Ortiz MR; Barrabés S; Reis CA; Peracaula R
    Int J Biol Macromol; 2018 Jun; 112():33-45. PubMed ID: 29408556
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor cell MUC1 and CD43 are glycosylated differently with sialyl-Lewis a and x epitopes and show variable interactions with E-selectin under physiological flow conditions.
    Fernandez-Rodriguez J; Dwir O; Alon R; Hansson GC
    Glycoconj J; 2001; 18(11-12):925-30. PubMed ID: 12820726
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunohistochemical expression of sialyl Lex antigen in relation to survival of patients with colorectal carcinoma.
    Nakagoe T; Fukushima K; Hirota M; Kusano H; Ayabe H; Tomita M; Kamihira S
    Cancer; 1993 Oct; 72(8):2323-30. PubMed ID: 8104679
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of sialyl Lewis(a), sialyl Lewis(x), and sialyl Tn antigens expression levels as predictors of recurrence after curative surgery in node-negative colorectal cancer patients.
    Nakagoe T; Fukushima K; Tanaka K; Sawai T; Tsuji T; Jibiki M; Nanashima A; Yamaguchi H; Yasutake T; Ayabe H; Arisawa K
    J Exp Clin Cancer Res; 2002 Mar; 21(1):107-13. PubMed ID: 12071515
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aberrant expression of MUC5AC and MUC6 gastric mucins and sialyl Tn antigen in intraepithelial neoplasms of the pancreas.
    Kim GE; Bae HI; Park HU; Kuan SF; Crawley SC; Ho JJ; Kim YS
    Gastroenterology; 2002 Oct; 123(4):1052-60. PubMed ID: 12360467
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.